First human tests begin for experimental prostate cancer treatment
NCT ID NCT07336446
Summary
This early-stage clinical trial is testing a new drug called AZD9750 in men with metastatic prostate cancer that has spread. Researchers will study the drug's safety, how it moves through the body, and early signs of effectiveness when given alone or combined with another cancer drug. The study will enroll about 300 participants to find the right dose and see if the treatment helps control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Duarte, California, 91010, United States
-
Research Site
Boston, Massachusetts, 02114, United States
-
Research Site
St Louis, Missouri, 63156, United States
-
Research Site
Myrtle Beach, South Carolina, 29572, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Melbourne, 3000, Australia
-
Research Site
Vancouver, British Columbia, V5Z 1H7, Canada
-
Research Site
Chūōku, 104-0045, Japan
-
Research Site
Kashiwa, 227-8577, Japan
Conditions
Explore the condition pages connected to this study.